Please use this identifier to cite or link to this item: https://doi.org/10.1182/blood-2009-07-235119
Title: Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
Authors: Thoennissen, N.H.
Krug, U.O.
Lee, D.H.T.
Kawamata, N.
Iwanski, G.B.
Lasho, T.
Weiss, T.
Nowak, D.
Koren-Michowitz, M.
Kato, M.
Sanada, M.
Shih, L.-Y.
Nagler, A.
Raynaud, S.D.
Müller-Tidow, C.
Mesa, R.
Haferlach, T.
Gilliland, D.G.
Tefferi, A.
Ogawa, S.
Phillip Koeffler, H. 
Issue Date: 8-Apr-2010
Citation: Thoennissen, N.H., Krug, U.O., Lee, D.H.T., Kawamata, N., Iwanski, G.B., Lasho, T., Weiss, T., Nowak, D., Koren-Michowitz, M., Kato, M., Sanada, M., Shih, L.-Y., Nagler, A., Raynaud, S.D., Müller-Tidow, C., Mesa, R., Haferlach, T., Gilliland, D.G., Tefferi, A., Ogawa, S., Phillip Koeffler, H. (2010-04-08). Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood 115 (14) : 2882-2890. ScholarBank@NUS Repository. https://doi.org/10.1182/blood-2009-07-235119
Abstract: Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) including polycythemia vera, essential thrombocythemia, and primary myelofibrosis show an inherent tendency for transformation into leukemia (MPN-blast phase), which is hypothesized to be accompanied by acquisition of additional genomic lesions.We, therefore, examined chromosomal abnormalities by high-resolution single nucleotide polymorphism (SNP) array in 88 MPN patients, as well as 71 cases with MPN-blast phase, and correlated these findings with their clinical parameters. Frequent genomic alterations were found in MPN after leukemic transformation with up to 3-fold more genomic changes per sample compared with samples in chronic phase (P < .001). We identified commonly altered regions involved in disease progression including not only established targets (ETV6, TP53, and RUNX1) but also new candidate genes on 7q, 16q, 19p, and 21q. Moreover, trisomy 8 or amplification of 8q24 (MYC) was almost exclusively detected in JAK2V617F- cases with MPN-blast phase. Remarkably, copy number-neutral loss of heterozygosity (CNN-LOH) on either 7q or 9p including homozygous JAK2V617F was related to decreased survival after leukemic transformation (P = .01 and P = .016, respectively). Our high-density SNP-array analysis of MPN genomes in the chronic compared with leukemic stage identified novel target genes and provided prognostic insights associated with the evolution to leukemia. © 2010 by The American Society of Hematology.
Source Title: Blood
URI: http://scholarbank.nus.edu.sg/handle/10635/126840
ISSN: 00064971
DOI: 10.1182/blood-2009-07-235119
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

100
checked on May 24, 2022

WEB OF SCIENCETM
Citations

94
checked on May 17, 2022

Page view(s)

122
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.